Sarepta Therapeutics
The Scientist II, RNA Process Development at Sarepta contributes to the development and characterization of RNA-based drug substances, supporting manufacturing and process optimization. The role involves synthetic route design, impurity analysis, scale-up, and cross-functional collaboration to advance RNA therapeutics.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Synthetic or Medicinal Chemist
mountsinaihospital.com
Associate Principal Scientist, Process Chemistry
Merck & Co., Inc.
Principal Scientist, Analytical Development
Bristol Myers Squibb
Scientist, Peptide Chemistry
Neurocrine Biosciences
Principal Chemist - IPS-Synthesis & API Mfg
MRIGlobal
Process Development Senior Scientist
Amgen